Semler Scientific (NASDAQ:SMLR – Get Free Report) posted its earnings results on Monday. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.08, Yahoo Finance reports. The firm had revenue of $14.47 million for the quarter. Semler Scientific had a net margin of 32.92% and a return on equity of 30.36%.
Semler Scientific Trading Up 4.6 %
Shares of SMLR traded up $1.20 during mid-day trading on Tuesday, hitting $27.52. 568,647 shares of the company’s stock were exchanged, compared to its average volume of 204,204. The firm has a market capitalization of $194.57 million, a P/E ratio of 9.86 and a beta of 1.00. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $53.38. The business’s 50 day moving average is $33.41 and its two-hundred day moving average is $34.00.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital raised shares of Semler Scientific to a “strong-buy” rating in a research report on Wednesday, May 8th.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles
- Five stocks we like better than Semler Scientific
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- Short Selling: How to Short a Stock
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.